Cargando…
Neuron-Astrocyte Interactions in Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease. PD patients exhibit motor symptoms such as akinesia/bradykinesia, tremor, rigidity, and postural instability due to a loss of nigrostriatal dopaminergic neurons. Although the pathogenesis in sporadic PD remains unknown, th...
Autores principales: | Miyazaki, Ikuko, Asanuma, Masato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762285/ https://www.ncbi.nlm.nih.gov/pubmed/33297340 http://dx.doi.org/10.3390/cells9122623 |
Ejemplares similares
-
Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2016) -
Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2023) -
Glutathione and Related Molecules in Parkinsonism
por: Asanuma, Masato, et al.
Publicado: (2021) -
3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of l-DOPA
por: Asanuma, Masato, et al.
Publicado: (2016) -
l-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes
por: Takeshima, Mika, et al.
Publicado: (2016)